Y. Yazici And H. Yazici, "Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events," Annual European Congress of Rheumatology (EULAR 2004) , vol.63, Berlin, Germany, pp.504, 2004
Yazici, Y. And Yazici, H. 2004. Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events. Annual European Congress of Rheumatology (EULAR 2004) , (Berlin, Germany), 504.
Yazici, Y., & Yazici, H., (2004). Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events . Annual European Congress of Rheumatology (EULAR 2004) (pp.504). Berlin, Germany
Yazici, Y, And H Yazici. "Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events," Annual European Congress of Rheumatology (EULAR 2004), Berlin, Germany, 2004
Yazici, Y And Yazici, H. "Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events." Annual European Congress of Rheumatology (EULAR 2004) , Berlin, Germany, pp.504, 2004
Yazici, Y. And Yazici, H. (2004) . "Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events." Annual European Congress of Rheumatology (EULAR 2004) , Berlin, Germany, p.504.
@conferencepaper{conferencepaper, author={Y Yazici And author={H Yazici}, title={Annual incidence risk in the general population is an inappropriate comparator for reporting TNF-alpha antagonist associated adverse events}, congress name={Annual European Congress of Rheumatology (EULAR 2004)}, city={Berlin}, country={Germany}, year={2004}, pages={504} }